RHY 4.76% 6.0¢ rhythm biosciences limited

Reading today’s ann, perhaps this test has a broader application...

  1. 1,531 Posts.
    lightbulb Created with Sketch. 145
    Reading today’s ann, perhaps this test has a broader application across a younger demographic as well compared to the age bracket discussed in the NYT article. I note Dr He from Concord hospital talking about colorectal cancer being the leading cause of cancer related deaths in patients 30-35 year olds. Dr He’s quote really says it all:

    ”Concord Repatriation General HospitalConcord has both a nationally and internationally acknowledged centre of excellence in colorectal surgery. It services the extensive health network within the Sydney Local Health District, and it is also one of the premier teaching hospitals in NSW and indeed Australia. The Gastroenterology department has a deep experience in clinical trials, conducting over 50 trials in the last 5 years.

    Dr Emily He, commented:“With colorectal cancer now the leading cause of cancer related deaths for 30-35 year-olds in both male and females in Australia, the time is right for a simple and effective blood test for early detection that can be adopted by all ages of the population on a mass scale.””
    Last edited by kiwig: 19/01/21
 
watchlist Created with Sketch. Add RHY (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.